+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carboplatin"

Ovarian Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Ovarian Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Small Cell Lung Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Small Cell Lung Cancer Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Glioblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 440 Pages
  • Global
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
High-Grade Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

High-Grade Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
Advanced ovarian cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced ovarian cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 210 Pages
  • Global
From
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
From
From
Loading Indicator

Carboplatin is a chemotherapy drug used to treat lung cancer. It is a platinum-based drug, which works by interfering with the growth of cancer cells. It is often used in combination with other drugs, such as paclitaxel, to treat non-small cell lung cancer. Carboplatin is also used to treat other types of cancer, such as ovarian and bladder cancer. Carboplatin is generally well-tolerated, with fewer side effects than other chemotherapy drugs. Common side effects include nausea, vomiting, and hair loss. It is important to note that Carboplatin can cause serious side effects, such as kidney damage and hearing loss. The Carboplatin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Bristol-Myers Squibb, Merck, and AstraZeneca. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of Carboplatin. Show Less Read more